|
Group I - Proteoglycans |
|
|
|
High molecular weight aggregates are formed by the binding of multiple lectican polypeptides, through link modules, to a molecule of hyaluronan. Lectican aggregates have structural roles in the extracellular matrix. The resilience of cartilage, which cushions joints, is due to the hydrated glycosaminoglycan chains of aggrecan. Furthermore, the glycosaminoglycan chains and globular domains of lecticans can bind cell surface molecules, matrix components, and extracellular signalling molecules through interactions with protein, lipid or carbohydrate. These interactions are modulated by spatial and temporal variations in lectican expression, splicing, proteolysis, and glycosylation, and by other ligands and signalling molecules. As a consequence, lecticans have complex effects on cell communication, adhesion, migration, proliferation, differentiation and apoptosis. The modulation of these events by lecticans is implicated in development, tissue remodelling, and disease, including cancer and arthritis.
The CTLDs in lecticans appear to be of the galactose-binding subtype. The CRD of aggrecan exhibits calcium-dependent binding to galactose and related sugars, but the physiological role of this carbohydrate recognition remains unknown. Lectican CTLDs also participate in protein-protein interactions. |
|
Structure of rat aggrecan CTLD bound to fibronectin type III repeats 3-5 of tenascin-R
The aggrecan CTLD is shown in red (alpha-helices) and blue (beta-strands). Ca2+ ions are shown in dark blue. Tenascin R is shown in yellow. Protein Data Bank structure ID: 1TDQ. |
|
______________________________________________________________________________________________________________________________
|
|
|
| Contact information: | This site is supported by: | |
|
|
|
![]() |
||